Χώρα: Ηνωμένες Πολιτείες
Γλώσσα: Αγγλικά
Πηγή: NLM (National Library of Medicine)
trenbolone acetate (UNII: RUD5Y4SV0S) (trenbolone - UNII:P53R4420TR)
Merck Sharp & Dohme Corp.
trenbolone acetate
trenbolone 200 mg
SUBCUTANEOUS
OTC
Increases rate of weight gain and improves feed efficiency in a slow-release delivery system. This product is to be used in feedlot heifers only during approximately the last 63 days prior to slaughter. Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established.
Box of 10 × 10 cartridge implants.
New Animal Drug Application
FINAPLIX-H- TRENBOLONE ACETATE IMPLANT MERCK SHARP & DOHME CORP. ---------- FINAPLIX -H (TRENBOLONE ACETATE) For Heifers Fed In Confinement For Slaughter DESCRIPTION Finaplix -H (trenbolone acetate) is an implant containing 200 mg of trenbolone. Each implant consists of 10 small yellow pellets. Ten implants are provided in a cartridge. MANUFACTURED BY A NON-STERILIZING PROCESS. INDICATIONS FOR USE Increases rate of weight gain and improves feed efficiency in a slow-release delivery system. This product is to be used in feedlot heifers only during approximately the last 63 days prior to slaughter. Do not use in veal calves. Effectiveness and animal safety in veal calves have not been established. DOSAGE One implant containing 200 mg trenbolone acetate is administered to each animal. The 10 pellets which make up the dosage of Finaplix -H are contained in one division of the multiple dose cartridge. Ten doses are in each cartridge. The cartridge is designed to be used with a special implant gun. ROUTE OF ADMINISTRATION The implant is placed under the skin on the posterior aspect of the ear by means of a special implanter available from Intervet Inc. With the animal suitably restrained, the skin on the outer surface of the ear should be cleaned. The implant is then administered by the method shown in the diagram below. ® ® ® SITE OF IMPLANTATION After appropriately restraining the animal to allow access to the ear, cleanse the skin at the implant needle puncture site. It is subcutaneous between the skin and cartilage on the back side of the ear and below the midline of the ear. The implant must not be placed closer to the head than the edge of the cartilage ring farthest from the head. The location of insertion of the needle is a point toward the tip of the ear and at least a needle length away from the intended deposition site. Care should be taken to avoid injuring the major blood vessels or cartilage of the ear. METHOD OF USE 1. Do not remove the cap of the cartridge containing the implants. 2. Place the cartri Διαβάστε το πλήρες έγγραφο